Radiopharm Theranostics Ltd
RADXNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for RADX. That does not mean none is planned.
Get an email about RADX's next catalysts
Track Radiopharm Theranostics (RADX) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
0 upcoming, 0 past
No catalysts found.
Market Overview
Stock performance and key metrics
177Lu-BetaBart
Castration-Resistant Prostate Cancer (CRPC)
RAD101 (18F-FPIA)
Brain Metastases From Solid Tumors
161Tb RAD402
Castration-resistant Prostate Cancer
BetaBart + unlabeled BetaBart
Castration-Resistant Prostate Cancer (CRPC)
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
177Lu-BetaBart | Phase 2 | Castration-Resistant Prostate Cancer (CRPC) | - | - |
RAD101 (18F-FPIA) | Phase 2 | Brain Metastases From Solid Tumors | - | - |
161Tb RAD402 | Phase 2 | Castration-resistant Prostate Cancer | - | - |
BetaBart + unlabeled BetaBart | Phase 2 | Castration-Resistant Prostate Cancer (CRPC) | - | - |
Frequently asked questions
What is in Radiopharm Theranostics Ltd's drug pipeline?β
CatalystAlert tracks 4 drug candidates in Radiopharm Theranostics Ltd's (RADX) pipeline across Phase 2. Its lead program is 161Tb RAD402 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Radiopharm Theranostics Ltd's next FDA catalyst?β
CatalystAlert tracks every upcoming catalyst for Radiopharm Theranostics Ltd (RADX) β PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β each confidence-rated as confirmed, estimated or AI-detected.
How do I track RADX biotech catalysts?β
Add RADX to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Radiopharm Theranostics Ltd's live catalyst calendar, drug pipeline and clinical-trial timeline on this page β sourced from ClinicalTrials.gov, FDA and SEC filings.
